Role of TGF-ß1 in renal parenchymal scarring following childhood urinary tract infection

Kidney International

Volumn 61, Issue 1, 2002, Pages 61-67

  Cotton, S A ^a   Gbadegesin, R A ^a   Williams, S ^a   Brenchley, Paul E C ^a   Webb, Nicholas J A ^a  

^a MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

800 GA genotype; Bacterial infection; Fibrosis; Pediatric nephropathy; Polymorphisms; Transforming growth factor J31

Indexed keywords

DNA; LEUCINE; LIPOPOLYSACCHARIDE; PHYTOHEMAGGLUTININ; PROLINE; TRANSFORMING GROWTH FACTOR BETA1; TGFB1 PROTEIN, HUMAN; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CELL ISOLATION; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DISEASE COURSE; DNA ISOLATION; DNA POLYMORPHISM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROSIS; GENOTYPE; HUMAN; HUMAN CELL; IN VITRO STUDY; KIDNEY PARENCHYMA; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; PROTECTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SCAR FORMATION; URINARY TRACT INFECTION; CHILD; GENE FREQUENCY; GENETICS; IMMUNOLOGY; INFANT; KIDNEY; PATHOLOGY; PRESCHOOL CHILD; SCAR;

CHILD; CHILD, PRESCHOOL; CICATRIX; FEMALE; FIBROSIS; GENE FREQUENCY; GENOTYPE; HUMANS; INFANT; KIDNEY; LEUKOCYTES, MONONUCLEAR; MALE; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; URINARY TRACT INFECTIONS;

EID: 0036007130     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2002.00110.x     Document Type: Article

References (35)

1. The paediatric registry of the European Dialysis and Transplant Association: 20 years' experience
2. Followup of conservatively treated children with high and low grade vesicoureteral reflux: A prospective study
3. The value of level diagnosis of childhood urinary tract infection in predicting renal injury
4. Urinary tract infection in children. Part I: Epidemiology, natural history, diagnosis and management
5. Renal damage one year after first urinary tract infection: Role of dimercaptosuccinic acid scintigraphy
6. Implications of certain genetic polymorphisms in scarring in vesicoureteric reflux: Importance of ACE polymorphism
7. Local cytokine production in a murine model of Escherichia coli pyelonephritis
8. Mechanisms of renal tissue destruction in an experimental acute pyelonephritis
9. L-651,392, a potent leukotriene inhibitor, controls inflammatory process in Escherichia coli pyelonephritis
10. The possible role of granulocyte elastase in renal damage from acute pyelonephritis
11. Interleukin-1 alpha and interleukin-1 receptor antagonist in the urine of children with acute pyelonephritis and relation to renal scarring
12. Urine interleukin-6 and interleukin-8 in children with acute pyelonephritis, in relation to DMSA scintigraphy in the acute phase and at 1-year follow-up
13. Cytokine gene expression during experimental Escherichia coli pyelonephritis in mice
14. Transforming growth factor beta in tissue fibrosis
15. Polymorphisms of the transforming growth factor-beta 1 gene in relation to myocardial infarction and blood pressure. The Etude Cas-Temoin de l'Infarctus du Myocarde (ECTIM) Study
16. Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth
17. Effects of transforming growth factor beta on the functions of natural killer cells: Depressed cytolytic activity and blunting of interferon responsiveness
18. Expression and secretion of type beta transforming growth factor by activated human macrophages
19. Effects of transforming growth factor-beta on human lymphokine-activated killer cell precursors. Autocrine inhibition of cellular proliferation and differentiation to immune killer cells
20. The autocrine production of transforming growth factor-beta 1 during lymphocyte activation. A study with a monoclonal antibody-based ELISA
21. Genotypic variation in the transforming growth factor-beta1 gene: Association with transforming growth factor-beta1 production, fibrotic lung disease, and graft fibrosis after lung transplantation
22. Characterization of the promoter region of the human transforming growth factor-beta 1 gene
23. Intron-exon structure of the human transforming growth factor-beta precursor gene
24. Transforming growth factor beta 1 in renal allograft recipients
25. Post-transcriptional regulation of the human transforming growth factor-beta 1 gene
26. Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor
27. Oncogene jun encodes a sequence-specific trans-activator similar to AP-1
28. The jun proto-oncogene is positively autoregulated by its product, Jun/AP-1
29. Transforming growth factor beta 1 positively regulates its own expression in normal and transformed cells
30. Mechanisms of transactivation by retinoic acid receptors
31. Induction of transforming growth factor beta autocrine activity by all-trans retinoic acid 1[alpha]-25-dihydroxy-vitamin D-3 in NRO-152 rat prostatic epithelial cells
32. Guidelines for the management of acute urinary tract infection
33. Ultrasonography versus DMSA scan in children with vesicoureteric reflux
34. Transient pyelonephritic changes on 99m Technetium-dimercaptosuccinic acid scan for at least five months after infection
35. Role of angiotensin II in the expression and regulation of transforming growth factor-beta in obstructive nephropathy